M&T Bank’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.46M Sell
17,803
-2,652
-13% -$660K 0.02% 415
2025
Q4
$5.63M Sell
20,455
-170
-0.8% -$46.5K 0.02% 379
2025
Q3
$5.41M Sell
20,625
-1,189
-5% -$289K 0.02% 365
2025
Q2
$4.77M Sell
21,814
-56,186
-72% -$12M 0.02% 420
2025
Q1
$17.5M Sell
78,000
-1,474
-2% -$406K 0.06% 216
2024
Q4
$26M Sell
79,474
-1,351
-2% -$425K 0.09% 173
2024
Q3
$24.3M Buy
80,825
+273
+0.3% +$83.6K 0.08% 179
2024
Q2
$26.5M Sell
80,552
-795
-1% -$281K 0.09% 174
2024
Q1
$32.2M Buy
81,347
+608
+0.8% +$225K 0.11% 150
2023
Q4
$28.4M Sell
80,739
-1,031
-1% -$365K 0.1% 163
2023
Q3
$30.7M Buy
81,770
+54,472
+200% +$21.1M 0.12% 142
2023
Q2
$10.4M Sell
27,298
-946
-3% -$338K 0.04% 303
2023
Q1
$9.79M Sell
28,244
-1,638
-5% -$479K 0.04% 317
2022
Q4
$7.03M Sell
29,882
-26,936
-47% -$6.38M 0.03% 359
2022
Q3
$14M Buy
56,818
+1,241
+2% +$378K 0.06% 243
2022
Q2
$15.4M Sell
55,577
-4,649
-8% -$1.51M 0.07% 198
2022
Q1
$24.7M Sell
60,226
-3,361
-5% -$1.32M 0.11% 160
2021
Q4
$29.8M Buy
63,587
+303
+0.5% +$130K 0.13% 149
2021
Q3
$26.9M Buy
63,284
+383
+0.6% +$161K 0.12% 153
2021
Q2
$22.6M Buy
62,901
+255
+0.4% +$84.3K 0.1% 173
2021
Q1
$17.7M Buy
62,646
+386
+0.6% +$110K 0.08% 203
2020
Q4
$17.6M Buy
62,260
+1,337
+2% +$375K 0.08% 190
2020
Q3
$16.7M Sell
60,923
-1,244
-2% -$329K 0.08% 181
2020
Q2
$14.1M Buy
62,167
+4,667
+8% +$917K 0.08% 196
2020
Q1
$8.76M Buy
57,500
+2,559
+5% +$394K 0.05% 255
2019
Q4
$8.26M Sell
54,941
-1,178
-2% -$172K 0.04% 218
2019
Q3
$7.96M Sell
56,119
-18,827
-25% -$2.59M 0.04% 273
2019
Q2
$9.38M Sell
74,946
-37
-0% -$4.37K 0.05% 254
2019
Q1
$8.26M Sell
74,983
-6,386
-8% -$664K 0.04% 262
2018
Q4
$7.98M Buy
81,369
+1,513
+2% +$164K 0.05% 251
2018
Q3
$9.86M Sell
79,856
-387
-0.5% -$43.4K 0.05% 247
2018
Q2
$7.97M Sell
80,243
-1,533
-2% -$141K 0.04% 276
2018
Q1
$7.22M Buy
81,776
+1,643
+2% +$154K 0.04% 290
2017
Q4
$7.91M Buy
80,133
+17,957
+29% +$1.76M 0.04% 283
2017
Q3
$5.99M Buy
62,176
+121
+0.2% +$10.9K 0.03% 318
2017
Q2
$5.87M Buy
62,055
+2,348
+4% +$216K 0.03% 316
2017
Q1
$4.87M Sell
59,707
-4,951
-8% -$414K 0.03% 332
2016
Q4
$5.49M Buy
64,658
+932
+1% +$73.3K 0.03% 311
2016
Q3
$4.75M Buy
63,726
+522
+0.8% +$41.4K 0.03% 333
2016
Q2
$4.79M Sell
63,204
-3,190
-5% -$232K 0.03% 332
2016
Q1
$4.6M Sell
66,394
-181
-0.3% -$10.9K 0.03% 342
2015
Q4
$4.01M Sell
66,575
-1,341
-2% -$80.7K 0.03% 368
2015
Q3
$3.67M Sell
67,916
-91,762
-57% -$5.35M 0.03% 393
2015
Q2
$9.28M Sell
159,678
-40,313
-20% -$2.25M 0.06% 241
2015
Q1
$12M Sell
199,991
-12,117
-6% -$646K 0.08% 205
2014
Q4
$11.3M Sell
212,108
-28,481
-12% -$1.42M 0.07% 213
2014
Q3
$10.8M Buy
240,589
+225,587
+1,504% +$9.59M 0.07% 222
2014
Q2
$632K Buy
15,002
+805
+6% +$34.5K 0.03% 374
2014
Q1
$625K Sell
14,197
-161
-1% -$7.58K 0.03% 364
2013
Q4
$705K Sell
14,358
-5,686
-28% -$266K 0.03% 332
2013
Q3
$824K Buy
20,044
+4,554
+29% +$174K 0.04% 269
2013
Q2
$544K Buy
+15,490
New +$510K 0.03% 308

Other funds holding WST

M&T Bank's WST Position: Q1 2026 in Review

M&T Bank reduced its West Pharmaceutical (WST) stake by 13% in Q1 2026, selling an estimated $660K and leaving 17,803 shares worth $4.46M. The position accounts for 0.02% of the portfolio, ranked #415.

M&T Bank first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.2M in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • M&T Bank held 17,803 shares of West Pharmaceutical worth $4.46M as of Q1 2026.
  • M&T Bank sold 2,652 West Pharmaceutical shares in Q1 2026, an estimated $660K.
  • West Pharmaceutical made up 0.02% of M&T Bank's portfolio in Q1 2026, its #415 holding.
  • M&T Bank first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
  • M&T Bank's West Pharmaceutical position peaked at $32.2M in Q1 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.